ESC 365 - Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome

Back

ESC Professional Premium Access

Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry

Session: Pharmacotherapy in acute coronary syndromes

Topic: Thrombosis, Platelets, and Coagulation

Speaker: Mr A. Haakansson (Lund, SE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Mr Anton Haakansson

Skane University Hospital, Lund (Sweden)

0 follower

4 more presentations in this session

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Speaker: Professor G. Montalescot (Paris, FR)

Access

Slides

Video

Incidence and pattern of repeat coronary revascularizations in patients with acute coronary syndromes treated with ticagrelor or prasugrel

Speaker: Doctor A. Aytekin (Munich, DE)

SGLT-2 inhibitors are associated with lower rates of mortality following myocardial infarction in patients with type 2 diabetes - A SWEDEHEART observational study

Speaker: Doctor H. Rosen (Lund, SE)

Current concepts of treatment for left ventricular thrombus: A sys-tematic meta-analysis comparing direct oral anticoagulants versus vitamin K-antagonists

Speaker: Mr T. Seiler (Bern, CH)

Access the full session

Pharmacotherapy in acute coronary syndromes

Speakers: Mr A. Haakansson, Professor G. Montalescot, Doctor A. Aytekin, Doctor H. Rosen, Mr T. Seiler

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources